Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/376)
- Verger, A, Cecchin, D, Guedj, E, Albert, NL, Brendel, M, Fraioli, F et al.. Correction to: EANM perspectives for CZT SPECT in brain applications. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06842-3. PubMed PMID:39017919 .
- Bobot, M, Bruno, J, Burtey, S. Cognitive Impairment Phenotypes in Patients with CKD Stages 3b and 4. Kidney360. 2024;5 (6):787-788. doi: 10.34067/KID.0000000000000474. PubMed PMID:38935489 PubMed Central PMC11219103.
- Brendel, M, Guedj, E, Yakushev, I, Morbelli, S, Höglinger, GU, Tolboom, N et al.. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06803-w. PubMed PMID:38907856 .
- Bobot, M, Heim, X, Max, H, Boucraut, J, Simeone, P, Stein, C et al.. Prospective Multicenter Study on Early Proximal Tubular Injury in COVID-19-Related Acute Respiratory Distress Syndrome. Kidney Int Rep. 2024;9 (6):1641-1653. doi: 10.1016/j.ekir.2024.03.011. PubMed PMID:38899195 PubMed Central PMC11184390.
- Albert, NL, Preusser, M, Traub-Weidinger, T, Tolboom, N, Law, I, Palmer, JD et al.. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06783-x. PubMed PMID:38898354 .